# OnCo record nct06800313 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct06800313/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct06800313", "NCT06800313" ;
  schema:name "Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer"@en ;
  schema:description "A phase 1/2 trial of JNJ-101556143 Formulation 1 in prostate cancer, run by Janssen Research & Development, LLC, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct06800313/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06800313> ;
  onco:status "recruiting" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "1/2" ;
  schema:startDate "2025-02-06" ;
  onco:cancers <https://onco.cc/cancers/prostate/> ;
  onco:companies <https://onco.cc/companies/johnson-johnson/> .
